Arthex Biotech closes EUR 42m funding round

Our banking and finance team has advised Arthex Biotech on the closing of a €42 million Series B financing round.

The round was led by Columbus Venture Partners and also had participation from the European Innovation Council (EIC), Hadean Ventures, Sound Bioventures and previous investors Invivo Capital, AdBio Partners and CDTI.